Use of avacopan with a lower dose of glucocorticoids leads to fewer total and serious side effects, as well as infections.

Sea's SPM-0404 and a second-generation molecule SPM-0606 represent a portfolio strategy of discovery and development of potent, selective, CNS-penetrant molecules targeting excitatory glutamate ...

Ohio voters have until Monday to register to vote in this May's primary and special elections. With the May 6 election fast approaching and early voting opening Tuesday, here are the races to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Researchers at UC San Francisco have achieved a remarkable breakthrough in brain-computer interface (BCI) technology, enabling individuals with paralysis to control robotic devices through thought ...

Primary central nervous system histiocytic sarcoma (PCNSHS) is even rarer. We present the case of a 50-year-old Asian male with PCNSHS who was hospitalized after experiencing intermittent headaches ...

The report published on Tuesday named India and China as “sources of precursors and equipment for drug traffickers and the primary source countries for illicit fentanyl precursor chemicals and pill ...

Mapping the density, molecular features and energy-transformation capacity of cell organelles called mitochondria in the brain reveals region- and cell-type-specific variability that tracks with ...

Objective: The aim of this study was to compare prognostic factors and survival outcomes in patients with primary central nervous system lymphoma (PCNSL). Methods: The Surveillance, Epidemiology, and ...

Furthermore, its primary mechanism of action, topoisomerase II inhibition, is agnostic to specific tumor histology, making it a potentially more generalizable therapy." CNS Chief Executive Officer ...

Furthermore, its primary mechanism of action, topoisomerase II inhibition, is agnostic to specific tumor histology, making it a potentially more generalizable therapy." CNS Chief Executive Officer ...